Pantoprazole Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

144 API Suppliers, 58 USDMF, 50 CEP/COS, 41 EU WC, 18 KDMF, 30 NDC API, 87 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

32 Intermediates Suppliers

32 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

1117 FDF Dossiers, 63 FDA Orange Book, 682 Europe, 38 Canada, 67 Australia, 71 South Africa, 196 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE, INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 1 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 5 DKSH, 5 Faran Shimi Pharmaceutical, 7 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 6 Actylis, 2 Aeon Procare, 3 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 35 BASF, 2 Clariant, 16 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 13 Gangwal Chemicals, 15 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

90 Fillers, Diluents & Binders, 77 Coating Systems & Additives, 51 Direct Compression, 45 Controlled & Modified Release, 37 Disintegrants & Superdisintegrants, 32 Solubilizers, 32 Thickeners and Stabilizers, 29 Granulation, 28 Taste Masking, 23 Lubricants & Glidants, 22 Film Formers & Plasticizers, 21 Chewable & Orodispersible Aids, 21 Parenteral, 21 Co-Processed Excipients, 20 Topical, 9 Emulsifying Agents, 7 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 60 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 640 Finished Drug Prices, 9 Annual Reports

MARKET PLACE

64 APIs, 55 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 1 US Exclusivities, 22 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 21 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20988 / DOSAGE - INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
PANTOPRAZOLE SODIUM(UNII: 6871619Q5X) (PANTOPRAZOLE - UNII:D8TST4O562)	PANTOPRAZOLE	40mg in 10

Inactive Ingredients

Ingredient Name	Camber Pharmaceuticals, Inc.	Cardinal Health	Civica, Inc.	Fresenius Kabi USA, LLC	Novadoz Pharmaceuticals LLC	Teva Pharmaceuticals USA, Inc.	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
EDETATE DISODIUM(7FLD91C86K)
SODIUM HYDROXIDE(55X04QC32I)

Drug Product Composition: Pantoprazole Sodium